| 2023/03/07 18:00:00 | |
|---|---|
| Price | |
| 104.082 CHF | |
| Difference | 0.64% (0.67) |
General attributes
| ISIN | US58933Y1055 |
| Symbol | MRK |
| Exchange | BX Swiss |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 250,389 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 98.127 CHF (1,078) |
| Ask (Ask size) | 98.225 CHF (1,078) |
| Open | 104.082 CHF |
| High | 104.082 CHF |
| Low | 104.082 CHF |
| Close (prev. day) | 103.416 CHF |
| VWAP | 104.082 CHF |
| Volume (pcs) | 30 |
| Trading volume | 3,122.40 |
| Number of trades | 1 |
| Last size | 30 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: MERCK & CO. INC. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/03/16 |
|
Global Equity Ratings |
|
| 2023/03/10 |
|
Global Equity Ratings |
|
| 2023/02/27 |
|
Global Equity Ratings |
|
| 2023/02/07 |
|
Global Equity Ratings |
|
| 2023/01/30 |
|
Global Equity Ratings |
|
| 2023/03/07 18:00:00 | |
|---|---|
| Price | |
| 104.082 CHF | |
| Difference | 0.64% (0.67) |
General attributes
| ISIN | US58933Y1055 |
| Symbol | MRK |
| Exchange | BX Swiss |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 250,389 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 98.127 CHF (1,078) |
| Ask (Ask size) | 98.225 CHF (1,078) |
| Open | 104.082 CHF |
| High | 104.082 CHF |
| Low | 104.082 CHF |
| Close (prev. day) | 103.416 CHF |
| VWAP | 104.082 CHF |
| Volume (pcs) | 30 |
| Trading volume | 3,122.40 |
| Number of trades | 1 |
| Last size | 30 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | - | - | - |
| Perf (abs.) | - | - | - |
| Beta | 0.26 | 0.29 | 0.46 |
| Volatility | 70.38 | 70.38 | 70.38 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 100.866 CHF (126) |
| Ø price 30 days | Ø volume 30 days (pcs.) | - CHF (107) |
| Ø price 100 days | Ø volume 100 days (pcs.) | - CHF (107) |
| Ø price 250 days | Ø volume 250 days (pcs.) | - CHF (107) |
| YTD High | date | 104.082 CHF (2023/03/07) |
| YTD Low | date | 94.186 CHF (2023/02/03) |
| 52 Weeks High | date | 104.082 CHF (2023/03/07) |
| 52 Weeks Low | date | 94.186 CHF (2023/02/03) |
All listings for MERCK & CO. INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2023/03/20 | 17:35 | 99.10 EUR | 0.18 | 47 |
| Vienna Stock Exchange | 2023/03/20 | 17:32 | 99.10 EUR | 0.00 | 1 |
| Tradegate | 2023/03/20 | 22:26 | 98.80 EUR | 0.25 | 50 |
| Stuttgart | 2023/03/20 | 20:01 | 98.60 EUR | 0.02 | 5 |
| SIX Swiss Exchange | 2020/02/03 | 17:36 | 75.00 USD | 0.00 | 1 |
| SIX Swiss Exchange | 2022/12/05 | 17:36 | 400.00 CHF | 0.00 | 1 |
| NYSE | 2023/03/20 | 21:03 | 105.85 USD | 1,361.79 | 88,468 |
| Munich | 2023/03/20 | 08:00 | 95.90 EUR | 0.00 | 1 |
| London Stock Exchange | 2023/03/20 | 17:35 | 106.10 USD | 0.00 | 2 |
| Hanover | 2023/03/20 | 08:01 | 96.00 EUR | 0.00 | 1 |
| Hamburg | 2023/03/20 | 08:01 | 96.00 EUR | 0.00 | 1 |
| Frankfurt | 2023/03/20 | 15:20 | 99.30 EUR | 0.01 | 4 |
| Euronext Paris | 2023/03/20 | 16:33 | 99.40 EUR | 0.07 | 16 |
| Duesseldorf | 2023/03/20 | 21:00 | 98.20 EUR | 0.00 | 13 |
| Berlin | 2023/03/20 | 20:21 | 98.40 EUR | 0.00 | 15 |
| BX Swiss | 2023/03/07 | 18:00 | 104.082 CHF | 0.00 | 1 |
Company Logo
Contact Details
| MERCK & CO. INC. |
| - - |
| 2000 Galloping Hill Road - 07033 Kenilworth |
| Telefon: +1-908-740-4000 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: MERCK & CO. INC. | |
Company Profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ. |
Members of Management Board
| Christine Seidman | Member of Board of Directors |
| Paul Rothman | Member of Board of Directors |
| Risa Lavizzo-Mourey | Member of Board of Directors |
| Stephen Mayo | Member of Board of Directors |
| Douglas Baker | Member of Board of Directors |
| Inge Thulin | Member of Board of Directors |
| Kathy Warden | Member of Board of Directors |
| Mary Coe | Member of Board of Directors |
| Pamela Craig | Member of Board of Directors |
| Patricia Russo | Member of Board of Directors |
| Peter Wendell | Member of Board of Directors |
| Thomas Glocer | Member of Board of Directors |
| Robert M. Davis | Chairman of Managing Board |
| Dean Y. Li | Member of Executive Committee |
| Caroline Litchfield | Member of Executive Committee |
| Cristal N. Downing | Member of Executive Committee |
| Dave Williams | Member of Executive Committee |
| Frank Clyburn | Member of Executive Committee |
| Jennifer Zachary | Member of Executive Committee |
| Julie L. Gerberding | Member of Executive Committee |
| Michael A. Klobuchar | Member of Executive Committee |
| Richard R. DeLuca Jr. | Member of Executive Committee |
| Sanat Chattopadhyay | Member of Executive Committee |
| Steven C. Mizell | Member of Executive Committee |